» Articles » PMID: 6610841

Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Overview
Journal Neurology
Specialty Neurology
Date 1984 Jul 1
PMID 6610841
Citations 8015
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical criteria for the diagnosis of Alzheimer's disease include insidious onset and progressive impairment of memory and other cognitive functions. There are no motor, sensory, or coordination deficits early in the disease. The diagnosis cannot be determined by laboratory tests. These tests are important primarily in identifying other possible causes of dementia that must be excluded before the diagnosis of Alzheimer's disease may be made with confidence. Neuropsychological tests provide confirmatory evidence of the diagnosis of dementia and help to assess the course and response to therapy. The criteria proposed are intended to serve as a guide for the diagnosis of probable, possible, and definite Alzheimer's disease; these criteria will be revised as more definitive information become available.

Citing Articles

Investigation of the role of miRNA variants in neurodegenerative brain diseases.

Frydas A, Cacace R, van der Zee J, Van Broeckhoven C, Wauters E Front Genet. 2025; 16:1506169.

PMID: 40078479 PMC: 11897046. DOI: 10.3389/fgene.2025.1506169.


Longitudinal trajectories of cognitive, functional, and neuropsychiatric decline in Alzheimer's disease during COVID-19 lockdown in South Korea.

Lee H, Shin S, Nam G, Kwak S, Cho Y, Hwang E Sci Rep. 2025; 15(1):8081.

PMID: 40057581 PMC: 11890767. DOI: 10.1038/s41598-025-92497-5.


Talking during walking: the diagnostic potential of turn dynamics in Alzheimer's disease, mild cognitive impairment and cognitive aging.

Mohammadi H, Maghsoudpour A, Noroozian M, Mohammadian F Front Aging Neurosci. 2025; 17:1533573.

PMID: 40046785 PMC: 11880252. DOI: 10.3389/fnagi.2025.1533573.


Plasma exosomal miRNA expression and gut microbiota dysbiosis are associated with cognitive impairment in Alzheimer's disease.

Lin K, Lin W, Guo Z, Chen C, Chen L, Cai X Front Neurosci. 2025; 19:1545690.

PMID: 40046438 PMC: 11880238. DOI: 10.3389/fnins.2025.1545690.


Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements.

Ding H, Ye Z, Paschalidis A, Bennett D, Au R, Lin H Alzheimers Dement. 2025; 21(3):e70055.

PMID: 40042504 PMC: 11881628. DOI: 10.1002/alz.70055.